针刺疗法联合丙酸氟替卡松治疗持续性变应性鼻炎:随机对照试验研究方案
本研究为多中心、单盲、随机对照试验,计划纳入260例持续性变应性鼻炎患者,随机分为针刺联合丙酸氟替卡松鼻喷剂组与单用丙酸氟替卡松鼻喷剂组,治疗6周,随访24周。主要结局为反射性鼻部症状总评分(rTNSS)自基线至治疗结束的变化,旨在评估联合治疗的有效性。
要点
- 针刺联合丙酸氟替卡松鼻喷剂与单用丙酸氟替卡松鼻喷剂进行对照。
- 主要结局为rTNSS自基线至治疗结束的变化。
- 计划纳入260例持续性变应性鼻炎患者,治疗6周后随访24周。
核心结论
- 该临床试验将为针刺疗法联合丙酸氟替卡松鼻喷剂治疗持续性变应性鼻炎提供高级别证据。
研究设计与样本
- 多中心、单盲、随机对照试验,计划纳入260例符合条件的持续性变应性鼻炎患者。
- 患者随机分为治疗组或对照组,治疗组接受丙酸氟替卡松鼻喷剂联合针刺,对照组单用丙酸氟替卡松鼻喷剂,疗程6周。
- 治疗结束后随访24周。
主要发现
- 主要结局为反射性鼻部症状总评分(rTNSS)自基线至治疗结束的变化。
- 次要结局包括鼻部以外症状总评分(TNNSS)、反射性眼部症状总评分(rTOSS)、鼻结膜炎生活质量问卷(RQLQ)、抗过敏药物使用情况及鼻炎控制评估测试(RCAT)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Allergic rhinitis (AR) is an immunoglobulin E (IgE)-mediated inflammatory response. Persistent allergic rhinitis (PAR) is a subtype of AR, but the treatment of PAR is still a problem. Acupuncture is used as an alternative therapy for AR in clinical practice. The aim of this study is to evaluate the effectiveness of acupuncture therapy combined with fluticasone propionate nasal spray in comparison to fluticasone propionate nasal spray alone in the relief of symptoms for PAR. METHODS: This study is a multicenter, single-blind, randomized controlled trial. A total of 260 eligible patients will be randomly assigned into the treatment group or the control group. The treatment group will receive the nasal fluticasone propionate combined with acupuncture, and the control group will receive fluticasone propionate nasal spray alone for 6 weeks. The primary outcome is the change in the Reflective Total Nasal Symptom Score (rTNSS) from baseline to the end of treatment, and the Total Non Nasal Symptom Score (TNNSS), reflective total ocular symptom score (rTOSS), Rhinitis Quality of Life Questionnaire (RQLQ), use of antiallergic drugs, and the Rhinitis Control Assessment Test (RCAT) are used as secondary outcomes. The participants will be followed up for another 24 weeks after treatment. DISCUSSION: This clinical trial will be able to provide high level evidence on the acupuncture therapy combined with fluticasone propionate nasal spray in the treatment of PAR. TRIAL REGISTRATION: ISRCTN Registry, ID: ISRCTN44040506 . Registered on 22 July 2020.
引用
- Fan Q, Feng Y, Hou Y, et al. Effect of acupuncture therapy combined with fluticasone propionate in the treatment of persistent allergic rhinitis: study protocol for a randomized controlled trial. Trials. 2022. PMID: 35101086. doi:10.1186/s13063-022-06020-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。